GLP-1s

New Advisory Offers First Consensus in Prescribing GLP-1s

Anywhere from 6% to 12% of the US population has taken a GLP-1 agonist. But until now there hasn’t been a cohesive message among physicians for how to care for this growing patient population. Last month the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society released a joint advisory […]

New Advisory Offers First Consensus in Prescribing GLP-1s Read More »

The Undervalued Medical Power of Muscle

The exponential rise of our aging population. The pandemic. The explosion of GLP-1s. It’s a trifecta that’s making muscle — and the serious implications of not having enough of it — part of a larger health conversation. Yet when I recently asked my 65-year-old mom whether her doctor had ever talked to her about resistance

The Undervalued Medical Power of Muscle Read More »

Scroll to Top